DE69734709D1 - Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden - Google Patents

Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden

Info

Publication number
DE69734709D1
DE69734709D1 DE69734709T DE69734709T DE69734709D1 DE 69734709 D1 DE69734709 D1 DE 69734709D1 DE 69734709 T DE69734709 T DE 69734709T DE 69734709 T DE69734709 T DE 69734709T DE 69734709 D1 DE69734709 D1 DE 69734709D1
Authority
DE
Germany
Prior art keywords
drug
carboxyl group
group
spacer
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69734709T
Other languages
English (en)
Inventor
Shuichi Sugawara
Masahiro Kajiki
Hiroshi Kuriyama
Nobuya Kitaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Chemicals Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Kasei Chemicals Corp
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Chemicals Corp, Asahi Chemical Industry Co Ltd filed Critical Asahi Kasei Chemicals Corp
Application granted granted Critical
Publication of DE69734709D1 publication Critical patent/DE69734709D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE69734709T 1996-04-15 1997-04-15 Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden Expired - Lifetime DE69734709D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11525796 1996-04-15
JP32588096 1996-11-22
PCT/JP1997/001303 WO1997038727A1 (fr) 1996-04-15 1997-04-15 Composite medicamenteux

Publications (1)

Publication Number Publication Date
DE69734709D1 true DE69734709D1 (de) 2005-12-29

Family

ID=26453799

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69734709T Expired - Lifetime DE69734709D1 (de) 1996-04-15 1997-04-15 Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden

Country Status (7)

Country Link
US (1) US6458347B1 (de)
EP (1) EP0895784B1 (de)
JP (2) JP4420472B2 (de)
AT (1) ATE310538T1 (de)
CA (1) CA2251742C (de)
DE (1) DE69734709D1 (de)
WO (1) WO1997038727A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0895784B1 (de) * 1996-04-15 2005-11-23 Asahi Kasei Kabushiki Kaisha Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden
US6541508B2 (en) 1999-09-13 2003-04-01 Nobex Corporation Taxane prodrugs
US6380405B1 (en) * 1999-09-13 2002-04-30 Nobex Corporation Taxane prodrugs
US6713454B1 (en) 1999-09-13 2004-03-30 Nobex Corporation Prodrugs of etoposide and etoposide analogs
CN1543356B (zh) * 2001-06-25 2011-09-28 味之素株式会社 抗肿瘤剂
TWI313609B (en) * 2001-08-21 2009-08-21 Mitsubishi Tanabe Pharma Corp Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10324710A1 (de) 2003-05-30 2004-12-16 Supramol Parenteral Colloids Gmbh Stärkederivatkomplexe
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
US7282590B2 (en) * 2004-02-12 2007-10-16 The Research Foundation Of State University Of New York Drug conjugates
RU2375384C2 (ru) 2004-09-22 2009-12-10 Ниппон Каяку Кабусики Кайся Новый блок-сополимер, мицеллярный препарат и противораковое средство, включающее мицеллярный препарат в качестве активного ингредиента
US9603941B2 (en) * 2006-01-24 2017-03-28 Minghui Chai Method of preparing dendritic drugs
WO2007111211A1 (ja) * 2006-03-28 2007-10-04 Nippon Kayaku Kabushiki Kaisha タキサン類の高分子結合体
RU2447095C2 (ru) 2006-05-18 2012-04-10 Ниппон Каяку Кабусики Кайся Высокомолекулярный конъюгат подофиллотоксинов
US20080108138A1 (en) * 2006-06-13 2008-05-08 Vermette Patrick Bioactive compositions and their use in cell patterning
CA2664852A1 (en) * 2006-10-03 2008-04-10 Nippon Kayaku Kabushiki Kaisha High-molecular weight conjugate of resorcinol derivatives
WO2008056596A1 (en) 2006-11-06 2008-05-15 Nippon Kayaku Kabushiki Kaisha Polymeric derivative of nucleic acid metabolic antagonist
EP2090607B1 (de) 2006-11-08 2015-05-20 Nippon Kayaku Kabushiki Kaisha Polymerderivat eines nukleinsäuremetabolismus-antagonisten
WO2009041570A1 (ja) * 2007-09-28 2009-04-02 Nippon Kayaku Kabushiki Kaisha ステロイド類の高分子結合体
EP2258397B1 (de) 2008-03-18 2017-10-11 Nippon Kayaku Kabushiki Kaisha Polymerkonjugat aus einem physiologisch aktiven stoff
JP5366940B2 (ja) 2008-05-08 2013-12-11 日本化薬株式会社 葉酸若しくは葉酸誘導体の高分子結合体
JP5544357B2 (ja) 2009-05-15 2014-07-09 日本化薬株式会社 水酸基を有する生理活性物質の高分子結合体
CA2816997A1 (en) 2010-11-17 2012-05-24 Nippon Kayaku Kabushiki Kaisha Novel polymer derivative of cytidine metabolic antagonist
US9346923B2 (en) 2011-09-11 2016-05-24 Nippon Kayaku Kabushiki Kaisha Method for manufacturing block copolymer
US10675354B2 (en) 2013-07-10 2020-06-09 Seikagaku Corporation Glycosaminoglycan derivative and method for producing same
US10098962B2 (en) 2013-07-10 2018-10-16 Seikagaku Corporation Glycosaminoglycan derivative and method for producing same
WO2015071841A1 (en) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6067503A (ja) * 1983-09-24 1985-04-17 Kyowa Hakko Kogyo Co Ltd マイトマイシン類と多糖類との結合体
GB8500209D0 (en) * 1985-01-04 1985-02-13 Ceskoslovenska Akademie Ved Synthetic polymeric drugs
WO1993024476A1 (en) 1992-06-04 1993-12-09 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
GB9213077D0 (en) 1992-06-19 1992-08-05 Erba Carlo Spa Polymerbound taxol derivatives
DE4236237A1 (de) 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
US5646176A (en) 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
JP2610792B2 (ja) * 1993-02-26 1997-05-14 株式会社ディ・ディ・エス研究所 多糖誘導体および薬物担体
US6214345B1 (en) 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
JPH09504033A (ja) 1993-10-20 1997-04-22 エンゾン，インコーポレーテッド ２’−及び／又は７−置換タキソイド類
US5760072A (en) * 1995-12-29 1998-06-02 Pharmachemie B.V. Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy
NZ332234A (en) * 1996-03-12 2000-06-23 Pg Txl Company Lp Water soluble paclitaxel prodrugs formed by conjugating paclitaxel or docetaxel with a polyglutamic acid polymer and use for treating cancer
EP0895784B1 (de) * 1996-04-15 2005-11-23 Asahi Kasei Kabushiki Kaisha Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden

Also Published As

Publication number Publication date
WO1997038727A1 (fr) 1997-10-23
ATE310538T1 (de) 2005-12-15
JP4420472B2 (ja) 2010-02-24
JP2009287036A (ja) 2009-12-10
CA2251742A1 (en) 1997-10-23
US6458347B1 (en) 2002-10-01
EP0895784B1 (de) 2005-11-23
EP0895784A1 (de) 1999-02-10
CA2251742C (en) 2001-12-11
EP0895784A4 (de) 2003-03-19

Similar Documents

Publication Publication Date Title
DE69734709D1 (de) Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden
GB9309324D0 (en) Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
BR0013949A (pt) Prodroga de taxano, composição farmacêutica, e, método de tratamento de um paciente mamìfero
CA2057099A1 (en) Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
WO1996030010A3 (fr) Utilisation du fumagillol et ses derives pour preparer les medicaments destines a combattre les infections intestinales
EP1213285A3 (de) 4,5-Diphenyloxazolderivate und ihre Verendung als Blutplättchenaggregations-Inhibitoren
KR870007947A (ko) 황-함유 그룹에 의해 치환된 5-아미노-4-하이드록시 발레릴 유도체 및 그의 제조 방법
KR950014073A (ko) 이소퀴놀린
IE821846L (en) Carbamimidoyl-1-carbadethiapen-2-em-3 carboxylic acid
AR004670A1 (es) Compuestos derivados de acido amino sustituido arilo y heteroarilo carboxilico; composicion farmaceutica que los contiene; metodo para aliviar eldolor; procedimiento para preparar dichos compuestos y compuestos utiles como material de partida
AU5504694A (en) Substituted amic acid derivatives
EP0388956A3 (de) Phthalinidderivat, pharmazeutische Zubereitung und Verwendung
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
NZ223287A (en) 4-thiazolidine carboxylic acid derivatives and pharmaceutical compositions
AU4452693A (en) Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method ofuse thereof
EP0806421A4 (de) Derivate der chinolincarbonsäure
WO1989005580A1 (en) Improvements in or relating to avian control
ES2103161A1 (es) Derivados de cicloheptimidazol, metodo de fabricacion de los mismos y agentes terapeuticos que contienen estos compuestos.
EP0316712A3 (de) 22-Dechloroteicoplanine
AU3929789A (en) New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof, a process for the preparation thereof, the use thereof as medicinal agents, pharmaceutical products and intermediates
ES8802508A1 (es) Procedimiento para preparar derivados alquenicos.
TW427998B (en) Steroid esters, process for their production and their pharmaceutical use
FR2701944B1 (fr) Procédé d'hydroxycarbonylation de lactones en acides dicarboxyliques aliphatiques.
GB2008096A (en) (2-Oxo-pyrrolidine-1)- and (2-oxo- piperidine-1) carboxylic acid hydrazides, process for the manufacture thereof, and pharmaceutical preparations containing them

Legal Events

Date Code Title Description
8332 No legal effect for de